πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

14,283 results for β€œB” Clear

  1. Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    connective tissue diseases

    phase 3 small molecule active

    1 trial

  2. Benlysta 200 mg solution for injection in pre-filled syringe., Placebo for Belimumab Solution for Injection, 200 mg/mL. The placebo for Belimumab Solution for Injection, 200 mg/mL is provided as a sterile solution for subcutaneous (SC) injection in single-use prefilled syringes.

    GlaxoSmithKline

    Lung Diseases, Interstitial

    phase 3 small molecule active

    1 trial

  3. Benralizumab

    AstraZeneca

    Asthma

    phase 3 mab completed

    1 trial

  4. Benralizumab

    AstraZeneca

    Chronic Obstructive Pulmonary Disease

    phase 3 mab completed

    1 trial

  5. Benralizumab 30 mg

    AstraZeneca

    Nasal Polyposis

    phase 3 mab terminated

    1 trial

  6. Benralizumab Placebo for clinical trials is a sterile liquid solution presented in an accessorized prefilled syringe (APFS) for subcutaneous injection. Please refer to the IMPD documentation enclosed., Placebo, Fasenra 30 mg solution for injection in pre-filled syringe

    AstraZeneca AB

    Hypereosinophilic Syndrome (HES)

    phase 3 small molecule active

    1 trial

  7. Benzyl penicillin

    United Therapeutics Europe Ltd

    Pneumonia

    phase 3 small molecule completed

    1 trial

  8. Bepirovirsen

    GlaxoSmithKline

    Chronic Hepatitis B

    phase 3 small molecule completed

    1 trial

  9. Berotralstat, Orladeyo 150 mg hard capsules, Berotralstat, Berotralstat, Berotralstat

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema (HAE)

    phase 3 small molecule active

    1 trial

  10. Betahistine dihydrochloride, BETASERC 24 mg, comprimΓ©

    Lacuna Pharma Pty Ltd

    Menière's disease

    phase 3 small molecule active

    1 trial

  11. Betamethasone Microsphere (DE-102οΌ‰ Low Dose

    Santen Oy

    Diabetic Macular Edema

    phase 3 small molecule completed

    1 trial

  12. Bevacizumab

    Hospital Authority, Hong Kong

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  13. Bevacizumab

    Samsung Bioepis NL B.V.

    Lung Cancer

    phase 3 small molecule completed

    1 trial

  14. Bevacizumab

    Pfizer

    Renal Cell Carcinoma

    phase 3 small molecule completed

    1 trial

  15. Bevacizumab

    Hoffmann-La Roche

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  16. Bevacizumab

    Hoffmann-La Roche

    B-cell Lymphoma

    phase 3 small molecule terminated

    1 trial

  17. Bevacizumab-Pfizer

    Pfizer

    Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  18. Bexicaserin, LP352 (bexicaserin) Placebo Oral Solution

    Lacuna Pharma Pty Ltd

    Dravet Syndrome

    phase 3 small molecule active

    1 trial

  19. Bexotegrast, Placebo matching PLN-74809

    PLIANT THERAPEUTICS, INC.

    Idiopathic pulmonary fibrosis (IPF)

    phase 3 small molecule active

    1 trial

  20. Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed)

    GlaxoSmithKline

    Invasive meningococcal disease (IMD)

    phase 3 small molecule active

    1 trial

  21. Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Trumenba suspension for injection in pre-filled syringe Meningococcal group B vaccine (recombinant, adsorbed)

    Pari Pharma GmbH

    Asplenia

    phase 3 small molecule active

    1 trial

  22. Beyfortus 100 mg solution for injection in pre-filled syringe, Beyfortus 50 mg solution for injection in pre-filled syringe, Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

    Fondazione Telethon ETS

    Respiratory Syncytial Virus (RSV)

    phase 3 small molecule active

    1 trial

  23. Bias retraining

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 3 other completed

    1 trial

  24. Bictegravir

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 3 small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources